The Role of a Clinical Pharmacist in the Management of Type 2 Diabetic Patients in a Primary Medical Center in Jordan

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

April 24, 2023

Study Completion Date

April 24, 2023

Conditions
Pharmacist-Patient Relations
Interventions
OTHER

Collaborative approach of clinical pharmacist with physicians in a medical center

For those who allocated to the intervention group, the clinical pharmacist interviewed them at each monthly visit about 30 minutes before seeing physicians, the clinical pharmacist identified treatment related problems, provided medication counseling, answered questions asked by patients or physicians, encouraged compliance, offered instructions on self-monitoring of blood pressure and glucose levels, distributed educational materials about diabetes and emphasis was made on optimizing adherence to pharmacological and non- pharmacological therapy. the pharmacist interventions on treatment related problems (TRPs) and proposed patient care plans were discussed with treatng physicians who decided to accept or reject them.

Trial Locations (1)

Unknown

Abu-Nsair medical center, Amman

All Listed Sponsors
lead

University of Jordan

OTHER